Influvac Description

Influenza virus surface antigens (inactivated) (hemagglutinin and neuraminidase) of the following strains*: A/Sydney/5/2021 (H1N1)pdm09-like strain (A/Sydney/5/2021, SAN-013) 15 micrograms HA **; A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010) 15 micrograms HA **; B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) 15 micrograms HA ** per 0.5 mL dose.
* propagated in fertilized hens' eggs from healthy chicken flocks.
** hemagglutinin.
This vaccine complies with the World Health Organization (WHO) recommendation (southern hemisphere) and competent authority decision for the 2023 season.
Trivalent Influenza Vaccine (Surface Antigen, Inactivated) (Influvac) may contain traces of eggs (such as ovalbumin, chicken proteins), formaldehyde, cetyltrimethylammonium bromide, polysorbate 80 or gentamicin, which are used during the manufacturing process (see Contraindications).
Suspension for injection (IM/SC) in prefilled syringe: a colorless clear liquid, filled in single-dose syringes.
Excipients/Inactive Ingredients: Potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate and water for injections.